Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Nuwellis Q2 Earnings Call Postponement
-
NUWELLIS ANNOUNCES THE FIRST SUCCESSFUL OUTPATIENT APPLICATION OF THE AQUADEX SMARTFLOW® SYSTEM UNDER NEW CMS CODE
-
Nuwellis Stockholders Approve All Proposals at Special Meeting
-
John Erb, President and CEO of Nuwellis, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.
-
Nuwellis Regains Compliance with Nasdaq Listing Requirements
-
Nuwellis Announces Q2 Earnings Advisory
-
Nuwellis Announces Termination of REVERSE-HF Clinical Trial
-
Nuwellis Secures New U.S. Patent
-
Nuwellis Announces Appointment of John Erb as Chief Executive Officer
-
MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid...